Moving into the mainstream: healthcare professionals’ views of implementing treatment focussed genetic testing in breast cancer care

A proportion of breast cancers are attributable to BRCA1 or BRCA2 mutations. Technological advances has meant that mutation testing in newly diagnosed cancer patients can be used to inform treatment plans. Although oncologists increasingly deliver treatment-focused genetic testing (TFGT) as part of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Fam Cancer
Hlavní autoři: Hallowell, Nina, Wright, S., Stirling, D., Gourley, C., Young, O., Porteous, M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Netherlands 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560008/
https://ncbi.nlm.nih.gov/pubmed/30689103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10689-019-00122-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky